ALPS will randomize 3,000 adults across North America with nontraumatic OHCA , persistent or recurring VF/VT after 1 shock , and established vascular access to receive up to 450 mg amiodarone , 180 mg lidocaine , or placebo in the field using a double-blind protocol , along with standard resuscitation measures .